|

Carboplatin plus Paclitaxel Clinical Trials

3 actively recruiting trials across 1 location

Pipeline

Phase 2: 2Phase 3: 1

Top Sponsors

  • The University of Hong Kong2
  • Immutep S.A.S.1

Indications

  • Cancer3
  • Fallopian Tube Cancer2
  • Ovarian Cancer2
  • Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)1
  • Primary Peritoneal Carcinoma1

Other2 trials

Personalised Timing of Interval Debulking Surgery in Advanced Ovarian Cancer
Phase 2
Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer
Phase 2

Louisville, Kentucky1 trial

Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004)

Norton Cancer Institute - Audubon

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.